AT
About
AtaiBeckley is a biopharmaceutical company that develops rapid-acting mental-health therapies. Its pipeline includes an intranasal mebufotenin benzoate candidate (BPL-003) for treatment-resistant depression, a DMT buccal film, and an oral R-MDMA compound . The company conducts clinical trials and drug development in neuropsychiatric conditions.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 1,517 investors are based in Berlin, Berlin, Germany.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Berlin, Germany
Contact Information
linkedin.com/in/••••••••
Find more investors like AtaiBeckley
Search Investors